GE Ventures, Kaiser Permanente Ventures and existing backer Illumina Ventures have helped Genome Medical take its total funding to $23m
US-based precision healthcare provider Genome Medical has raised an amount likely to be $11m in a series A-1 round led by GE Ventures, a subsidiary of industrial product group General Electric.
Genomics technology provider Illumina and healthcare consortium Kaiser Permanente also took part in the round, through their Illumina Ventures and Kaiser Permanente Ventures units, as did venture firm capital Canaan Partners.
Genome Medical provides genetic consulting services to customers who can use its gene collection or blood drawing kits…
